S&P 500 may face selling pressure as systematic funds reach full exposure
Saba Capital Management, L.P., a significant shareholder in BlackRock (NYSE:BLK) Capital Allocation Term Trust (NYSE:BCAT), disclosed a sale of shares valued at approximately $786,734, according to a recent SEC filing. The trust, currently valued at $1.61 billion, offers investors an attractive dividend yield of 23% and trades at a P/E ratio of 8.78. The transaction, executed on March 10, 2025, involved the disposal of 52,240 shares at a price of $15.06 per share. Following this sale, Saba Capital holds 12,037,810 shares of the trust. The transaction reflects ongoing portfolio adjustments by Saba Capital, led by Boaz Weinstein, as it continues to manage its investments in the financial markets. BCAT has delivered a 14.19% return over the past year, though it currently trades near its 52-week low of $14.96. InvestingPro analysis reveals additional key insights about BCAT’s market position and financial health, with several more exclusive ProTips available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.